Regulatory Landscape for Antimicrobial Resistance

Antibiotic research and development have not met the urgent need for new antibiotics. While financial incentives and market reforms are critical for sustainable progress on the issue, addressing regulatory hurdles to accelerate approval of new antibiotics can also help their development and improve their access in emerging markets. One Health Trust researchers conducted a landscape analysis to study the current climate for antimicrobial innovation, focusing on regulatory challenges and opportunities for the approval of new antibiotics in Brazil, India, and South Africa.